Insight Molecular Diagnostics (IMDX) Receivables - Other (2017)

Insight Molecular Diagnostics' (IMDX) quarterly Receivables - Other came in at $55000.0 in Q3 2017, up 66.67% quarter-over-quarter from $33000.0 in Q2 2017.

Insight Molecular Diagnostics (IMDX) Receivables - Other (2017) Analysis & Trends

Insight Molecular Diagnostics has disclosed Receivables - Other across 1 years of filings, most recently posting $55000.0 for Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 29,902.70 Bn 29,902.24 Bn 1.11 Bn
2 Thermo Fisher Scientific 175.99 Bn 172.74 Bn 7.74 Bn
3 Danaher 129.87 Bn 124.18 Bn 3.59 Bn
4 Idexx Laboratories 44.75 Bn 44.55 Bn 722.74 Mn
5 Agilent Technologies 37.52 Bn 35.72 Bn 990.00 Mn
6 Iqvia Holdings 30.91 Bn 28.94 Bn 1.36 Bn
7 Natera 30.21 Bn 29.11 Bn 696.04 Mn
8 Illumina 24.19 Bn 23.04 Bn 721.00 Mn
9 Mettler Toledo International 23.12 Bn 23.06 Bn 555.82 Mn
10 Insight Molecular Diagnostics 4.34 Mn -24.59 Mn 15,000.00

Historic Data

Download Data
DateValue
Sep 30, 2017 55,000.00
Sep 30, 2017 55,000.00
Jun 30, 2017 33,000.00
Jun 30, 2017 33,000.00